Результаты поиска - R. Tarnawski

  • Отображение 1 - 10 результаты of 10
Отмена результатов
  1. 1
    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer

    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer по Jyoti Mayadev, Guihao Ke, Umesh Mahantshetty, M.D. Pereira, R. Tarnawski, Takafumi Toita

    Опубликовано 2022
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy

    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy по Emilia Staniewska, Karolina Grudzień, Magdalena Stankiewicz, Katarzyna Raczek-Zwierzycka, Justyna Rembak-Szynkiewicz, Zuzanna Nowicka, R. Tarnawski, Marcin Miszczyk

    Опубликовано 2024
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    DALSA: Domain Adaptation for Supervised Learning From Sparsely Annotated MR Images

    DALSA: Domain Adaptation for Supervised Learning From Sparsely Annotated MR Images по Michael Goetz, Christian Weber, F. Bińczyk, Joanna Polańska, R. Tarnawski, Barbara Bobek‐Billewicz, Ullrich Koethe, Jens Kleesiek, Bram Stieltjes, Klaus Maier‐Hein

    Опубликовано 2015
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

    Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, contr... по Burt Nabors, Karen Fink, Tom Mikkelsen, Danica Grujičić, R. Tarnawski, Do Hyun Nam, Maria Mazurkiewicz‐Bełdzińska, Michael Salacz, Lynn S. Ashby, Vittorina Zagonel, Roberta Depenni, James Perry, Christine Hicking, Martin Picard, Monika E. Hegi, Benoît Lhermitte, David A. Reardon

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer

    Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer по Marcin Kubeczko, Dorota Gabryś, Marzena Gawkowska‐Suwińska, Anna Polakiewicz-Gilowska, Alexander Jorge Cortez, Aleksandra Krzywon, Grzegorz Woźniak, Tomasz Latusek, Aleksandra Leśniak, K Swiderska, Marta Mianowska-Malec, Barbara Łanoszka, Konstanty Chomik, Mateusz Gajek, Anna Michalik, Elżbieta Nowicka, R. Tarnawski, Tomasz Rutkowski, Michał Jarząb

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    191MO KEYNOTE-355: Outcomes in patients who discontinued chemotherapy before pembrolizumab and in patients with immune-mediated AEs

    191MO KEYNOTE-355: Outcomes in patients who discontinued chemotherapy before pembrolizumab and in patients with immune-mediated AEs по Hope S. Rugo, David W. Cescon, S-A. Im, Mastura Md Yusof, Cristián Araneda, O. N. Lipatov, F. Cruz, Carlos H. Barrios, Roberto Hegg, Élise Martin, M.A. Torregroza Otero, Nicholas C. Turner, Péter Árkosy, R. Tarnawski, Vassiliki Karantza, W. Pan, Z. Guo, Javier Cortés

    Опубликовано 2023
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

    Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001 по Christian Marth, R. Tarnawski, Alexandra Tyulyandina, Sandro Pignata, Lucy Gilbert, Diego Kaen, María Jesús Rubio, Sophia Frentzas, Mario Beiner, Manuel Magallanes-Maciel, Laura Farrelly, Chel Hun Choi, Regina Berger, Christine Lee, Christof Vulsteke, Kosei Hasegawa, Elena Ioana Braicu, Xiaohua Wu, Jodi A. McKenzie, John J. Lee, Vicky Makker

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial

    O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, pl... по Bradley J. Monk, Takafumi Toita, Xiaohua Wu, Juan Carlos Vázquez Limón, Qi Zhou, R. Tarnawski, Masaki Mandai, Ronnie Shapira‐Frommer, Umesh Mahantshetty, Maria Del Pilar Estevez-Diz, Francisco Ramirez Godinez, Szilvia Varga, M.H. Leiva Gálvez, Jung‐Yun Lee, Yulia Kreynina, Kathryn Howells, Sophie Wildsmith, Hannah Dry, Ana Tablante Nunes, Jyoti Mayadev

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)

    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTEC... по Loren K. Mell, Igor Sirák, Lichun Wei, R. Tarnawski, Umesh Mahantshetty, Catheryn M. Yashar, Michael McHale, Ronghui Xu, Gordon Honerkamp‐Smith, Ruben Carmona, Mary E. Wright, Casey W. Williamson, Linda Kašaová, Nan Li, Stephen F. Kry, Jeff M. Michalski, Walter Bosch, William L. Straube, Julie K. Schwarz, Jessica Lowenstein, Steve Jiang, Cheryl Saenz, Steve Plaxe, John P. Einck, Chonlakiet Khorprasert, Paul P. Koonings, Terry A. Harrison, Mei Shi, Arno J. Mundt

    Опубликовано 2016
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomis... по Roger Stupp, Monika E. Hegi, Thierry Gorlia, Sara Erridge, James Perry, Yong-Kil Hong, Kenneth Aldape, Benoît Lhermitte, Torsten Pietsch, Danica Grujičić, Joachim P. Steinbach, Wolfgang Wick, R. Tarnawski, Do‐Hyun Nam, Peter Hau, Astrid Weyerbrock, Martin Klein, Chiung‐Chyi Shen, Nalini Rao, László Thurzó, Ulrich Herrlinger, Tejpal Gupta, Rolf‐Dieter Kortmann, Krystyna Adamska, Catherine McBain, Alba A. Brandes, J. C. Tonn, Oliver Schnell, Thomas Wiegel, Chae‐Yong Kim, Burt Nabors, David A. Reardon, Martin J. van den Bent, Christine Hicking, Andriy Markivskyy, Martin Picard, Michael Weller

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: